Findings

What do systematic reviews say?

3 questions · 3 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 33.3%Moderate 2 · 66.7%High 0 · 0%

Sulfasalazine vs corticosteroids

CDAI <150 at 24 weeks · patients with Induction of remission or response in Crohn's disease

Sulfasalazine probably leads to lower induction of remission (CDAI <150) compared with corticosteroids (moderate certainty).

1 finding from 1 review

Aminosalicylates for induction of remission or response in Crohn's disease 2016 · Cochrane Headline outcomes only
RR 0.68 [0.51, 0.91]
2 studies · 260 participants
Moderate

Sulfasalazine vs placebo

Remission · patients with Induction of remission or response in Crohn's disease

Sulfasalazine showed no clear difference in induction of remission (CDAI <150) (Random Effects Model) compared with placebo (moderate certainty).

1 finding from 1 review

Aminosalicylates for induction of remission or response in Crohn's disease 2016 · Cochrane Headline outcomes only
RR 1.38 [1, 1.89]
2 studies · 263 participants
Moderate

Sulfasalazine vs placebo

Induction of remission (CDAI <150), therapeutic response (VHI decrease >=25%) or clinical improvement · patients with Induction of remission or response in Crohn's disease

Sulfasalazine showed no clear difference in induction of remission (CDAI <150), therapeutic response (VHI… compared with placebo (low certainty).

1 finding from 1 review

Aminosalicylates for induction of remission or response in Crohn's disease 2016 · Cochrane Headline outcomes only
RR 1.52 [0.95, 2.43]
3 studies · 289 participants
Low